Long-Term Cardiovascular Effects of COVID-19

In many places worldwide, the worst part of the pandemic is still to come. Meanwhile, in other areas, the number of cases is rising again. In this context, the long-term effects of COVID-19 are starting to show.

COVID-19 efectos cardiovasculares

Many believe this is not a current issue, but it will definitely be a problem in the future.

It is paramount to detect cardiovascular morbidities and complications in order to mitigate active infections. These include myocarditis, infarction, stroke, venous thromboembolism and multisystem inflammatory syndrome in children.

There is little information about what happens after the acute phase; however, recent publications have begun to shed some light on its impact.

The work done by Dr. Puntmann et al. showed that 78% of adult patients who recovered from COVID-19 presented some type of myocardial involvement. Said involvement was, in most cases, an inflammation diagnosed by magnetic resonance imaging and positive ultra-sensitive troponin. The results derived from magnetic resonance imaging differ from those from autopsies. In the latter, the evidence of myocarditis from COVID-19 is up to 10x lower than in magnetic resonance imaging.


Read also: The Key We Are Overlooking in Peripheral Vascular Disease.


This difference between imaging and anatomical pathology may possibly be caused by overinterpretation of the former, which could be mimicking inflammation. Physiological and technical variables might play a role.

Other coronaviruses, such as SARS and MERS, caused myocarditis in extremely rare cases. Unless this new coronavirus SARS-CoV-2 is functionally different from its predecessors, we should not expect long-term cardiac inflammation.

This pandemic proven the importance of anatomical pathology studies. Quality autopsies made it possible to calibrate clinical, radiological, and laboratory findings during the course of the infection.


Read also: Dietary Supplements and Diets Show No Impact on Cardiovascular Risk.


These autopsies mostly showed that the large number of pathological findings in the cardiovascular system were secondary to inflammation and not directly caused by the virus.

Lastly, the public health risk caused by COVID-19 should be balanced with other more individual aspects of health, such as physical, mental, and emotional wellbeing.

Título original: An Urgent Need for Studies of the Late Effects of SARS-CoV-2 on the Cardiovascular System.

Referencia: Joseph J. Maleszewski et al. Circulation. 2020 Sep 24. Online before print. DOI: 10.1161/CIRCULATIONAHA.120.051362.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...